美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NETLease Corporate Real Estate ETF

26.79

+0.18100.68%

盤後：26.810.0190+0.07%19:30 EDT

成交量：7,452

成交額：19.94萬

市值：5,559.13萬

市盈率：- -

高：26.81

開：26.81

低：26.68

收：26.61

52周最高：28.43

52周最低：23.56

股本：207.50萬

流通股本：207.50萬

量比：0.68

換手率：0.36%

股息：1.25

股息率：4.67%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

超2萬億元！上海三大先導產業交出倍增答卷

據天空新聞報道，英國超市莫里森斯正就一筆價值8.03億美元的門店交易進行談判

港股異動 | 百奧賽圖-B(02315)升逾14% 近日與Whitehawk達成全球合作共同開發創新雙特異性抗體ADC

豪華酒店房地產投資信託基金Braemar Hotels & Resorts回應Al Shams不實指控

环球市场播报

安捷倫(A)擴充Altura色譜柱產品線兩款新品適配多肽、ADC、mRNA等生物藥檢測

從「旁觀者」到「追趕者」：諾華(NVS.US)斥資15億美元收購Myricx，ADC賽道再落關鍵一子

Realty Income攜手Cloud Capital及全球機構投資者組建程序化合資企業，投資超大規模數據中心，初始種子資產估值超60億美元

德國第二季度商業地產融資情緒大幅惡化

諾誠健華盤中升逾9% 自研靶向CDH17的新型ADC創新藥ICP-B208完成首例患者給藥

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/NETL/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NETL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","market":"US","secType":"STK","nameCN":"NETLease Corporate Real Estate ETF","latestPrice":26.791,"timestamp":1787601600000,"preClose":26.61,"halted":0,"volume":7452,"hourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.791,"latestTime":"19:30 EDT","volume":9,"amount":241.119,"timestamp":1787614206571,"change":0.019,"changeRate":0.000709,"amplitude":0},"delay":0,"changeRate":0.006801954152574256,"floatShares":2075000,"shares":2075000,"eps":0,"marketStatus":"已收盤","change":0.181,"latestTime":"08-24 16:00:00 EDT","open":26.8094,"high":26.81,"low":26.6796,"amount":199439.768808,"amplitude":0.0049,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":26.61,"sharesOutstanding":1775000,"nav":26.54,"aum":55070500,"dividendRate":0.046684,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":26.81,"preClose":26.791,"latestTime":"19:30 EDT","volume":9,"amount":241.119,"timestamp":1787614206571,"change":0.019,"changeRate":0.000709,"amplitude":0},"volumeRatio":0.683971,"impliedVol":0.0633,"impliedVolPercentile":0.0438},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NETL\",,,,,undefined,":{"symbol":"NETL","floatShares":2075000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.683971,"shares":2075000,"dividePrice":1.2507,"high":26.81,"amplitude":0.0049,"preClose":26.61,"low":26.6796,"week52Low":23.56,"pbRate":"--","week52High":28.4299,"institutionHeld":0,"latestPrice":26.791,"eps":0,"divideRate":0.046684,"volume":7452,"delay":0,"ttmEps":0,"open":26.8094,"prevYearClose":23.727,"prevWeekClose":26.61,"prevMonthClose":27.14,"prevQuarterClose":26.7001,"fiveDayClose":26.48,"twentyDayClose":27.9307,"sixtyDayClose":26.3675},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NETL\",params:#limit:5,,,undefined,":[{"date":"2026-07-29","symbol":"NETL","amount":0.105,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-29","defaultRemindTime":1785331800000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-31","payableDate":"2026-07-29","currency":"USD","dateTimestamp":1785297600000,"payDate":"2026-07-31"},{"date":"2026-06-26","symbol":"NETL","amount":0.105,"announcedDate":"2026-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-26","defaultRemindTime":1782480600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-26","currency":"USD","dateTimestamp":1782446400000,"payDate":"2026-06-30"},{"date":"2026-05-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-05-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-27","defaultRemindTime":1779888600000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-27","currency":"USD","dateTimestamp":1779854400000,"payDate":"2026-05-29"},{"date":"2026-04-28","symbol":"NETL","amount":0.105,"announcedDate":"2026-04-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-04-30"},{"date":"2026-03-27","symbol":"NETL","amount":0.105,"announcedDate":"2026-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-27","defaultRemindTime":1774618200000,"name":"NETLease Corporate Real Estate ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-27","currency":"USD","dateTimestamp":1774584000000,"payDate":"2026-03-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NETL\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-30","recordDate":"2019-12-31","paymentDate":"2020-01-02","value":0.031935,"currency":"USD"},{"executeDate":"2020-03-17","recordDate":"2020-03-18","paymentDate":"2020-03-19","value":0.0097783,"currency":"USD"},{"executeDate":"2020-03-31","recordDate":"2020-04-01","paymentDate":"2020-04-02","value":0.1912399,"currency":"USD"},{"executeDate":"2020-06-26","recordDate":"2020-06-29","paymentDate":"2020-06-30","value":0.2782635,"currency":"USD"},{"executeDate":"2020-09-15","recordDate":"2020-09-16","paymentDate":"2020-09-30","value":0.2792338,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NETL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NETL\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651637482","title":"超2萬億元！上海三大先導產業交出倍增答卷","url":"https://stock-news.laohu8.com/highlight/detail?id=2651637482","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651637482?lang=zh_tw&edition=fundamental","pubTime":"2026-07-15 06:26","pubTimestamp":1784067962,"startTime":"0","endTime":"0","summary":"2020年，上海市“十四五”规划建议明确提出：推动集成电路、生物医药、人工智能三大先导产业规模倍增。当年，上海三大先导产业规模总体约1万亿元。今年初，回顾2025年的上海政府工作报告传递明确数字：2025年，上海三大先导产业规模突破2万亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153806297375.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153806297375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QTOC","BK4231","IE00B3T34201.USD","XBI","VTHR","VGT","AIBU","NETL","BK4588","BK4581","AIFD","LU2463526074.USD","ARTY","BK4080","IP","SOXX","NBDS","SMHX","SMH","LU1481600234.SGD","SSG","FWD","FTXL","LU1169589451.USD","AGIX","BK4585","BK4535","SOXQ","AIPO","CUT","LU1169590202.USD","BK4136","ADC","SOXY","USD","WOOD","TARK","LU1487256676.USD","PSI","XSD","KOMP","TEKX","SOXS","SOXL","IPOS","CHPS","CHPY","LU1481599808.USD","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651132051","title":"據天空新聞報道，英國超市莫里森斯正就一筆價值8.03億美元的門店交易進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2651132051","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651132051?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 18:39","pubTimestamp":1783939191,"startTime":"0","endTime":"0","summary":"据天空新闻报道，英国超市莫里森斯正就一笔价值8.03亿美元的门店交易进行谈判路透7月13日-据天空新闻周一援引行业消息人士报道，英国超市集团莫里森斯（Morrisons）正与包括美国房地产投资信托基金Realty Income（O.N）在内的多家机构就一笔价值6亿英镑（8.0298亿美元）的房地产交易进行谈判。路透无法立即核实该报道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4S43F0TB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","SRHR","DFAR","RWR","BK4588","NETL","ERET","BK4585","BK4080","O"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650906760","title":"港股異動 | 百奧賽圖-B(02315)升逾14% 近日與Whitehawk達成全球合作 共同開發創新雙特異性抗體ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2650906760","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650906760?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 11:10","pubTimestamp":1783653039,"startTime":"0","endTime":"0","summary":"根据协议，百奥赛图将通过其自主研发的RenLite平台提供至多五款全人双特异性抗体，Whitehawk将结合其ADC连接子-载荷平台技术对这些抗体进行评估。Whitehawk随后可选择将由此产生的BsADC候选分子纳入其管线并推进开发。通过整合百奥赛图与Whitehawk的互补优势，本次合作旨在发掘具有差异化靶向机制和治疗潜力的BsADC候选分子。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK4588","BK1161","02315","BK0216","BK4080","BK4231","BK4585","ADC","KCAI","NETL","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649994721","title":"豪華酒店房地產投資信託基金Braemar Hotels & Resorts回應Al Shams不實指控","url":"https://stock-news.laohu8.com/highlight/detail?id=2649994721","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649994721?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 22:30","pubTimestamp":1783521000,"startTime":"0","endTime":"0","summary":"豪华酒店房地产投资信托基金Braemar Hotels & Resorts Inc．发布声明，就最大股东Al Shams Investments Limited及其主要负责人Wafic Said近期的一系列公开言论作出回应，称其指控毫无根据，并质疑Said的动机与过往记录。　　Braemar表示，尽管多次尝试与Said进行建设性沟通，但均遭拒绝。　　Braemar Hotels & Resorts是一家专注于豪华酒店和度假村领域的房地产投资信托基金，其投资组合涵盖美国本土及加勒比海地区的优质酒店资产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-08/doc-inihceis8353217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","SPRE","BLDG","REAI","IDGT","NETL","DTRE","VGSR","VRAI","AVRE","XSHD","BK4139","FPRO","GRI","ALTY","RWO","INDS","ASET","BK4585","KBWD","BK4588","IVRA","IYLD","ABLD","SPHD","MDIV","BK4550","IQRA","CSRE","HIPS","JPRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649499680","title":"安捷倫(A)擴充Altura色譜柱產品線兩款新品 適配多肽、ADC、mRNA等生物藥檢測","url":"https://stock-news.laohu8.com/highlight/detail?id=2649499680","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649499680?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 20:32","pubTimestamp":1783513936,"startTime":"0","endTime":"0","summary":"两款新品搭载安捷伦超惰性分离技术，是原有 Altura 液相耗材矩阵的重要补充。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/NjQzZWIwYjMxODE0NDMwMmFiMWMzYWFhZmVlYWI3MGY0MzQwNTkyOTA0MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjQzZWIwYjMxODE0NDMwMmFiMWMzYWFhZmVlYWI3MGY0MzQwNTkyOTA0MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302338","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","LU2092937221.SGD","LU2089279066.USD","BK4567","159839","LU2413666699.HKD","IE00BN0W2W23.USD","LU2041044095.USD","LU1165135440.EUR","LU2229751404.USD","A","LU1721429741.USD","LU2413666426.HKD","BK4585","BK4588","BK4121","NETL","LU1543694498.USD","ADC","BK4231","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU1721428933.USD","LU1721429402.USD","LU0347712357.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649137647","title":"從「旁觀者」到「追趕者」：諾華(NVS.US)斥資15億美元收購Myricx，ADC賽道再落關鍵一子","url":"https://stock-news.laohu8.com/highlight/detail?id=2649137647","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649137647?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 17:02","pubTimestamp":1783328521,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华已就收购英国生物技术企业Myricx Bio达成协议，交易总对价最高可达15亿美元。据诺华周一发布声明，Myricx股东将获得11亿美元预付款，以及最高4亿美元的潜在里程碑付款。2025年10月，诺华以120亿美元收购了Avidity Biosciences，成为当年规模最大的抗体相关交易。此次收购Myricx，正是其深耕肿瘤学核心领域、充实ADC管线的关键落子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0009355771.USD","LU0320765489.SGD","LU0070302665.USD","BK4588","BK4532","LU0211331839.USD","BK4578","IE00BFTCPJ56.SGD","MEDX","IE00BJT1NW94.SGD","BK4231","NVS","IE00B2B36J28.USD","LU0208291251.USD","ADC","BK4080","BK4007","NETL","IE0002141913.USD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156175490","title":"Realty Income攜手Cloud Capital及全球機構投資者組建程序化合資企業，投資超大規模數據中心，初始種子資產估值超60億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156175490","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156175490?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:45","pubTimestamp":1783323923,"startTime":"0","endTime":"0","summary":"6月30日 - Realty Income Corp宣布，其已与Cloud Capital及一家全球机构投资者组建一家程序化合资企业，旨在投资于超大规模数据中心领域。该合资企业的初始种子资产组合估值已超过60亿美元。\n根据公告，Realty Income Corp预计将投资高达14亿美元，以获取一个位于北弗吉尼亚州的三资产投资组合中45%的股权权益。该合资企业的收购计划分步进行：预计将于2026年第三季度收购一项已稳定运营的资产，并将在未来日期收购另外两项尚在开发中的资产。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFAR","NETL","ERET","BK4588","O","RWR","SRHR","BK4080","BK4585","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649641629","title":"德國第二季度商業地產融資情緒大幅惡化","url":"https://stock-news.laohu8.com/highlight/detail?id=2649641629","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649641629?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 15:33","pubTimestamp":1783323224,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HHH","NETL","BK4024"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649461757","title":"諾誠健華盤中升逾9% 自研靶向CDH17的新型ADC創新藥ICP-B208完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2649461757","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649461757?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 09:52","pubTimestamp":1783302720,"startTime":"0","endTime":"0","summary":"　　诺诚健华盘中涨超9%，截至发稿，股价上涨6.42%，现报13.92港元，成交额5426.90万港元。　　7月6日，据诺诚健华官微消息，公司宣布自主研发的靶向CDH17的新型ADC创新药ICP-B208完成首例患者给药。基于诺诚健华自主研发的ADC技术平台，ICP-208由人源化抗CDH17抗体通过蛋白酶可裂解连接子与公司自主开发的强效有效载荷偶联而成，可精准靶向肿瘤细胞，同时最大限度减少脱靶效应。目前，全球尚无CDH17靶向ADC新药上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-06/doc-inifvqsf1795989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","688428","ADC","BK4080","NETL","BK1574","159992","MEDX","BK0239","BK1161","06978","09969","BK4231"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":49,"code":"91000000","status":"200"}]}}